Hillhouse Capital Advisors
Latest statistics and disclosures from Hhlr Advisors's latest quarterly 13F-HR filing:
- Top 5 stock holdings are LEGN, FUTU, AVBP, MRVL, VIPS, and represent 68.46% of Hhlr Advisors's stock portfolio.
- Added to shares of these 10 stocks: VIPS (+$44M), FUTU (+$33M), Alamar Biosciences (+$26M), Odyssey Therapeutics (+$16M), NTES, LITE, NVDA, TXN, COHR, ZM.
- Started 6 new stock positions in Alamar Biosciences, NTES, ZM, Odyssey Therapeutics, RDGT, TXN.
- Reduced shares in these 10 stocks: ONC (-$307M), PDD (-$280M), BABA (-$218M), Clearw.a.hld. (-$32M), BEKE (-$29M), BULL (-$7.8M), MRVL, INTC, B, DDL.
- Sold out of its positions in B, ONC, AXIA, Clearw.a.hld., DDL, EWW, VNET, UXIN, China Jo-jo Drugstores.
- Hhlr Advisors was a net seller of stock by $-753M.
- Hhlr Advisors has $832M in assets under management (AUM), dropping by -50.26%.
- Central Index Key (CIK): 0001762304
Tip: Access up to 7 years of quarterly data
Positions held by Hillhouse Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Hhlr Advisors
Hhlr Advisors holds 35 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Legend Biotech Corp Sponsored Ads (LEGN) | 20.8 | $173M | 6.0M | 28.88 |
|
|
| Futu Hldgs Spon Ads Cl A (FUTU) | 19.9 | $166M | +24% | 1.8M | 93.74 |
|
| Arrivent Biopharma (AVBP) | 16.4 | $137M | 3.9M | 34.74 |
|
|
| Marvell Technology (MRVL) | 5.8 | $49M | -4% | 163k | 297.89 |
|
| Vipshop Hldgs Sponsored Ads A (VIPS) | 5.5 | $46M | +2682% | 3.5M | 13.26 |
|
| Pdd Holdings Sponsored Ads (PDD) | 4.6 | $38M | -87% | 500k | 76.28 |
|
| Ke Hldgs Sponsored Ads (BEKE) | 3.9 | $32M | -47% | 2.2M | 14.53 |
|
| Cytek Biosciences (CTKB) | 3.5 | $30M | 6.7M | 4.43 |
|
|
| Alamar Biosciences Common Stock | 3.1 | $26M | NEW | 957k | 27.09 |
|
| Alibaba Group Hldg Sponsored Ads (BABA) | 2.1 | $18M | -92% | 184k | 95.98 |
|
| Odyssey Therapeutics Common Stock | 1.9 | $16M | NEW | 832k | 18.71 |
|
| Yatsen Hldg Sponsored Ads (YSG) | 1.9 | $16M | 4.9M | 3.17 |
|
|
| Novabridge Biosciences Sponsored Ads (NBP) | 1.4 | $12M | 6.0M | 1.95 |
|
|
| Contineum Therapeutics Cl A (CTNM) | 1.3 | $11M | 669k | 16.39 |
|
|
| Maze Therapeatics (MAZE) | 1.3 | $11M | 366k | 29.84 |
|
|
| Agora Ads (API) | 1.0 | $8.4M | 2.1M | 3.99 |
|
|
| Taiwan Semiconductor Manufac Sponsored Ads (TSM) | 0.9 | $7.4M | 16k | 477.57 |
|
|
| Sagimet Biosciences Com Ser A (SGMT) | 0.7 | $5.6M | 725k | 7.73 |
|
|
| Netease Sponsored Ads (NTES) | 0.5 | $4.5M | NEW | 35k | 128.14 |
|
| Ge Aerospace Com New (GE) | 0.5 | $3.8M | 10k | 373.73 |
|
|
| Lumentum Hldgs (LITE) | 0.3 | $2.8M | +120% | 3.3k | 858.06 |
|
| NVIDIA Corporation (NVDA) | 0.3 | $2.8M | +112% | 14k | 200.09 |
|
| Tuya Sponsered Ads (TUYA) | 0.3 | $2.8M | 1.6M | 1.76 |
|
|
| Corning Incorporated (GLW) | 0.3 | $2.6M | +33% | 10k | 255.43 |
|
| Coherent Corp (COHR) | 0.3 | $2.5M | +50% | 6.4k | 394.47 |
|
| Webull Corp Ord Shs (BULL) | 0.2 | $2.0M | -79% | 310k | 6.52 |
|
| Intel Corporation (INTC) | 0.2 | $2.0M | -50% | 14k | 139.63 |
|
| Pacific Biosciences of California (PACB) | 0.2 | $1.5M | 919k | 1.68 |
|
|
| Texas Instruments Incorporated (TXN) | 0.2 | $1.4M | NEW | 4.8k | 298.07 |
|
| Mogu Spon Ads (MOGU) | 0.2 | $1.4M | 848k | 1.67 |
|
|
| Gossamer Bio (GOSS) | 0.1 | $819k | 5.0M | 0.16 |
|
|
| Equinox Gold Corp equities (EQX) | 0.1 | $783k | 81k | 9.72 |
|
|
| Zoom Communications Cl A (ZM) | 0.1 | $778k | NEW | 9.0k | 86.31 |
|
| Aligos Therapeutics Com New (ALGS) | 0.1 | $440k | 76k | 5.77 |
|
|
| Ridgetech Shs New (RDGT) | 0.0 | $204.000000 | NEW | 136.00 | 1.50 |
|
Past Filings by Hhlr Advisors
SEC 13F filings are viewable for Hhlr Advisors going back to 2018
- Hhlr Advisors 2026 Q2 filed Aug. 14, 2026
- Hhlr Advisors 2026 Q1 filed May 15, 2026
- Hhlr Advisors 2025 Q4 filed Feb. 17, 2026
- Hhlr Advisors 2025 Q3 filed Nov. 14, 2025
- Hhlr Advisors 2025 Q2 filed Aug. 14, 2025
- Hhlr Advisors 2025 Q1 filed May 15, 2025
- Hhlr Advisors 2024 Q4 filed Feb. 14, 2025
- Hhlr Advisors 2024 Q3 filed Nov. 14, 2024
- Hhlr Advisors 2024 Q2 filed Aug. 14, 2024
- Hhlr Advisors 2024 Q1 filed May 14, 2024
- Hhlr Advisors 2023 Q4 filed Feb. 14, 2024
- Hhlr Advisors 2023 Q3 filed Nov. 14, 2023
- Hhlr Advisors 2023 Q2 filed Aug. 14, 2023
- Hhlr Advisors 2023 Q1 filed May 15, 2023
- Hhlr Advisors 2022 Q4 filed Feb. 14, 2023
- Hhlr Advisors 2022 Q3 filed Nov. 14, 2022